A Multicenter, International, Prospective, Randomized, Vehicle Controlled, Assessor Blinded Study Performed in Subjects With Hard to Heal Wounds, to Evaluate the Efficacy and Safety of Enzymatic Debridement With EscharEx
Phase of Trial: Phase II
Latest Information Update: 01 Sep 2017
At a glance
- Drugs EscharEx (Primary)
- Indications Leg ulcer; Wounds
- Focus Therapeutic Use
- Sponsors MediWound
- 01 Sep 2017 Top-line results from the second cohort of this trial published in MediWound Media Release.
- 03 Aug 2017 According to a MediWound media release, the company has completed enrollment of 38 patients into the second cohort of this trial and expects to report topline results in early September.
- 21 Feb 2017 According to a MediWound media release, company has progressed for a second cohort of patients in this study and plan to report top-line data from this cohort around mid-2017.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History